Clinical Trial

RESCUE: Discontinuation of GLP-1

Terminated
View on ClinicalTrials.gov →
Why the trial stopped
Business decision
Summary
This study is designed to compare weight loss outcomes and safety of ESG versus lifestyle modification in patients with obesity who discontinued GLP-1 therapy due to intolerance or suboptimal weight loss.
Protocol Amendment History 2 changes
critical Trial terminated 2026-06-11
notable Enrollment reduced: 150 -> 18 participants 2026-06-11
Trial Details
NCT Number NCT07190794
Lead Sponsor Boston Scientific Corporation
Conditions Obesity
Enrollment 18 participants
Start Date 2025-12-17
Primary Completion 2026-05-26 (estimated)
Study Completion 2026-05-26 (estimated)
Updated on ClinicalTrials.gov 2026-07-24